Portfolio Companies



ExThera Medical Corporation is developing an affinity therapy for removing pathogens and cytokines from blood for the treatment of sepsis and other infectious diseases as well as blood purification.




Biomimedica, Inc   Boimimedica, which is incubating on our premises, is developing a polymer technology for replacing the damaged articular cartilage surface of joints.  The company has completed Series A funding.




COR Innovations, Inc   COR Innovations is developing solutions to prevent heart failure after an acute myocardial infarction.